image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 14 days, don't miss out!

JTC

April 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • JTC
  • Price:
  • 970p
The shares have been resilient during the sell-off, buoyed by its fast start to the “Cosmos era” period. The update for the 12 months ended December showed it’s achieved management’s guidance of 10%+ net organic revenue growth pa while EBITDA margins sit within the guidance range of 33-38% and cash conversion is anticipated to be at the top end of the 85%-90% range. A year of strong progress saw five acquisitions completed while the 16 September Citi Trust deal is set to complete by the end of Q2 25. As a result it’s well-placed to meet its Cosmos era target of doubling 2023 EBITDA within four years. Full year 2024 was a record year for new business wins with year-on-year growth of almost 16% to £35.7m with the US a key dri ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe